Frédéric Fasano
Director/Board Member chez Acesis Holdings Corp.
Fortune : 24 913 $ au 31/03/2024
Profil
Frédéric Fasano is currently a Director at the Institute of Corporate Directors, National Pharmaceutical Association, and Acesis Holdings Corp.
He was previously the President & Chief Executive Officer at Servier Canada, Inc. from 2006 to 2020.
He also served as the Chairman at Innovative Medicines Canada from 2017 to 2020 and as a Director at ILKOS THERAPEUTICS, Inc. from 2016 to 2020.
Mr. Fasano holds an MBA from ESSEC Business School and a doctorate from Université Paris-Saclay.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VALEO PHARMA INC CLASS A
0,20% | 21/11/2022 | 199 300 ( 0,20% ) | 24 913 $ | 31/03/2024 |
Postes actifs de Frédéric Fasano
| Sociétés | Poste | Début |
|---|---|---|
Acesis Holdings Corp.
 Acesis Holdings Corp. BiotechnologyHealth Technology Acesis Holdings Corp. functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders. The company was founded on October 3, 2022 and is headquartered in Lone Tree, CO. | Director/Board Member | - |
| National Pharmaceutical Association | Director/Board Member | - |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Director/Board Member | - |
Anciens postes connus de Frédéric Fasano
| Sociétés | Poste | Fin |
|---|---|---|
| VALEO PHARMA INC. | President | 21/11/2022 |
ILKOS THERAPEUTICS, Inc.
 ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology ILKOS THERAPEUTICS, Inc. operates as biotechnology firm. It develops drug and clinical solutions for the treatment of venous lower limb ulcers. The company is headquartered in Laval, Canada. | Director/Board Member | 01/12/2020 |
Servier Canada, Inc.
 Servier Canada, Inc. Pharmaceuticals: MajorHealth Technology Servier Canada, Inc. provides healthcare services. It manufactures pharmaceuticals for cardiology, diabetes, depression, venous disease and menopause. The company was founded in 1978 and is headquartered in Quebec, Canada. | Chief Executive Officer | 01/11/2020 |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Chairman | 01/11/2020 |
Formation de Frédéric Fasano
| ESSEC Business School | Masters Business Admin |
| Université Paris-Saclay | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VALEO PHARMA INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Institute of Corporate Directors
Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Commercial Services |
Servier Canada, Inc.
Servier Canada, Inc. Pharmaceuticals: MajorHealth Technology Servier Canada, Inc. provides healthcare services. It manufactures pharmaceuticals for cardiology, diabetes, depression, venous disease and menopause. The company was founded in 1978 and is headquartered in Quebec, Canada. | Health Technology |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
ILKOS THERAPEUTICS, Inc.
ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology ILKOS THERAPEUTICS, Inc. operates as biotechnology firm. It develops drug and clinical solutions for the treatment of venous lower limb ulcers. The company is headquartered in Laval, Canada. | Health Technology |
| National Pharmaceutical Association | |
Acesis Holdings Corp.
Acesis Holdings Corp. BiotechnologyHealth Technology Acesis Holdings Corp. functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders. The company was founded on October 3, 2022 and is headquartered in Lone Tree, CO. | Health Technology |
